Overview
- In cell studies, nanoflower-treated stem cells produced about twice the usual number of mitochondria and transferred two to four times more of them to nearby damaged cells.
- Recipient cells regained energy output and showed stronger survival, including after chemotherapy-like stress.
- The nanoparticles are roughly 100 nanometers across and made of molybdenum disulfide, which persists in cells longer than small molecules.
- Researchers say the approach operates without genetic modification or conventional drugs and could enable less frequent dosing, potentially monthly.
- The findings, led by Akhilesh K. Gaharwar and John Soukar at Texas A&M, are early-stage and confined to laboratory experiments, with safety and in vivo validation still required.